Compare IVDA & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVDA | BGLC |
|---|---|---|
| Founded | 2003 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7M | 4.3M |
| IPO Year | 2015 | 2019 |
| Metric | IVDA | BGLC |
|---|---|---|
| Price | $0.29 | $1.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 8.4M | 9.4K |
| Earning Date | 05-12-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.38 | 45.78 |
| EPS | ★ N/A | N/A |
| Revenue | $4,468,279.00 | ★ $7,424,911.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 132.98 | N/A |
| 52 Week Low | $0.21 | $1.07 |
| 52 Week High | $2.24 | $6.10 |
| Indicator | IVDA | BGLC |
|---|---|---|
| Relative Strength Index (RSI) | 45.80 | 42.89 |
| Support Level | $0.27 | $1.23 |
| Resistance Level | $0.34 | $1.88 |
| Average True Range (ATR) | 0.03 | 0.12 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 25.08 | 32.81 |
Iveda Solutions Inc offers smart city technologies globally, offering AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products). Geographically, the company operates in USA and Taiwan, majority of its revenue is generated from Taiwan.
BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.